Merand Pharma Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Seed

  • Investors
  • 7

Merand Pharma General Information

Description

Developer of microRNA therapeutics designed to treat patients suffering from peripheral arterial disease. The company's therapeutics treat patients by promoting angiogenesis or the development of new blood vessels, which leads to restored blood flow, enabling businesses to stabilize functional blood vessels of patients to increase perfusion recovery and reduce inflammation.

Contact Information

Website
www.merandpharma.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 7515 Cedar Road
  • Chesterland
  • OH 44026
  • United States
+1 (800)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Life Sciences
Corporate Office
  • 7515 Cedar Road
  • Chesterland
  • OH 44026
  • United States
+1 (800)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Merand Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Seed Round 20-Feb-2021 Completed Clinical Trials - Phase 1
2. Early Stage VC (Series A) 21-Jul-2019 Completed Clinical Trials - Phase 1
1. University Spin-Out 24-Apr-2018 Completed Startup
To view Merand Pharma’s complete valuation and funding history, request access »

Merand Pharma Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A
To view Merand Pharma’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Merand Pharma Patents

  • 3

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 2

    Pending

  • Expiring in next 12 mo

Merand Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3208765-A1 Agents, compositions, and methods for the treatment of hypoxia and ischemia-related disorders Pending 12-Feb-2021
AU-2022219031-A1 Agents, compositions, and methods for the treatment of hypoxia and ischemia-related disorders Pending 12-Feb-2021
US-20240294909-A1 Agents, compositions, and methods for the treatment of hypoxia and ischemia-related disorders Inactive 12-Feb-2021 C12N15/113

Merand Pharma Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
757 Angels Angel Group Minority
CAV Angels Angel Group Minority
Charlottesville Angel Network Angel Group Minority
Tiburon Venture Capital Minority
UVA LVG Seed Fund Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial

Merand Pharma FAQs

  • When was Merand Pharma founded?

    Merand Pharma was founded in 2018.

  • Where is Merand Pharma headquartered?

    Merand Pharma is headquartered in OH.

  • What industry is Merand Pharma in?

    Merand Pharma’s primary industry is Biotechnology.

  • Is Merand Pharma a private or public company?

    Merand Pharma is a Private company.

  • What is Merand Pharma’s current revenue?

    The current revenue for Merand Pharma is .

  • How much funding has Merand Pharma raised over time?

    Merand Pharma has raised $1.14M.

  • Who are Merand Pharma’s investors?

    757 Angels, CAV Angels, Charlottesville Angel Network, Tiburon, and UVA LVG Seed Fund are 5 of 7 investors who have invested in Merand Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »